Cargando…
Booster Effect of a Third mRNA-Based COVID-19 Vaccine Dose in Patients with Myeloid Malignancies
Autores principales: | Mori, Akio, Onozawa, Masahiro, Kobayashi, Mirei, Tsukamoto, Shihori, Senjo, Hajime, Ishio, Takashi, Yokoyama, Emi, Izumiyama, Koh, Saito, Makoto, Muraki, Haruna, Morioka, Masanobu, Teshima, Takanori, Kondo, Takeshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society of Hematology. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9671511/ http://dx.doi.org/10.1182/blood-2022-159849 |
Ejemplares similares
-
Booster effect of a third mRNA‐based COVID‐19 vaccine dose in patients with myeloid malignancies
por: Mori, Akio, et al.
Publicado: (2023) -
Humoral response to mRNA-based COVID-19 vaccine and booster effect of a third dose in patients with mature T cell and NK-cell neoplasms
por: Kobayashi, Mirei, et al.
Publicado: (2023) -
Humoral response to mRNA‐based COVID‐19 vaccine in patients with immune thrombocytopenia
por: Mori, Akio, et al.
Publicado: (2022) -
Humoral response to mRNA‐based COVID‐19 vaccine in patients with de novo and pre‐existing immune thrombocytopenia with exacerbation of thrombocytopenia after vaccination
por: Mori, Akio, et al.
Publicado: (2022) -
Humoral response to mRNA‐based COVID‐19 vaccine in patients with myeloid malignancies
por: Mori, Akio, et al.
Publicado: (2022)